In order to evaluate if SSTR2 and NCL can potentially be used for therapeutic delivery in NSCLC cells, we initially determined the relative mRNA expression levels by real-time PCR in the two NSCLC cell lines A549 and H1299 and in a panel of other cancer cell lines (Fig 1). This evidence concerns the gene NUCLEOLIN and non-small cell lung carcinoma.